SRX CARDIO LLC has a total of 22 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are REXAHN PHARMACEUTICALS INC, ZAKLADY FARM POLPHARMA SA and EUCLISES PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Hong Kong | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Microorganisms | |
#6 | Special acyclic compounds | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Barta Thomas E | 20 |
#2 | Monroe Kyle D | 18 |
#3 | Muehlemann Michael M | 16 |
#4 | Bourne Jonathan William | 14 |
#5 | Reece Margaret Thompson | 8 |
#6 | Nevalainen Vesa | 8 |
#7 | Bowers Simeon | 6 |
#8 | Pandey Anjali | 6 |
#9 | Bourne Jonathan W | 6 |
#10 | Meuhlemann Michael M | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020252383A2 | Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (pcsk9) | |
US2018250291A1 | Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use | |
US2018237381A1 | Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity | |
US2017246196A1 | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity | |
US2016083425A1 | Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels | |
KR20150127622A | Proprotein convertase subtilisin/kexin type 9 allosteric binding ligands to modulate serum low density lipoprotein |